ALB and COVID-19: Clinical research has revealed that continuous albumin supplementation for 3 or more consecutive days inhibits the hypercoagulable state of patients with COVID‐19 and improves the prognosis of patients with COVID‐19 and hypoalbuminemia (Table 2).